Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist approved for type 2 diabetes. Insurance coverage for diabetes is becoming more widespread, though prior authorization and step therapy are common. For weight loss, the branded product Zepbound (also tirzepatide) has its own coverage pathway. Without insurance, Mounjaro costs approximately $1,000 to $1,100 per month.
Key Facts
Check Your Specific Plan's Formulary
Coverage varies by plan. Use our formulary checker tool to look up your exact copay and restrictions.
Open Formulary CheckerFrequently Asked Questions
Mounjaro is a novel dual-mechanism biologic drug with no generic or biosimilar competition. Eli Lilly invested heavily in clinical trials and manufacturing. The high price reflects the patent-protected, first-in-class status of tirzepatide. Manufacturer savings programs and insurance coverage can significantly reduce out-of-pocket costs.
It depends on your diagnosis. Insurance typically covers Mounjaro for type 2 diabetes and Zepbound for weight management. They are the same molecule (tirzepatide) but different branded products with different NDC numbers. Your pharmacy cannot substitute one for the other. Check your formulary for the specific product matching your diagnosis.
Your doctor submits a prior authorization request to your insurer, including your diabetes diagnosis, current A1C, medications you have tried (usually metformin is required first), and clinical justification. Turnaround is typically 24 to 72 hours. If denied, you can appeal with additional documentation.
Related Resources
- UnitedHealthcare Formulary 2026
- Cigna Formulary 2026
- Aetna Formulary 2026
- Ozempic cash price comparison on RxGrab
- Zepbound cash price comparison on RxGrab
- Wegovy cash price comparison on RxGrab
- Jardiance cash price comparison on RxGrab
- Metformin cash price comparison on RxGrab
- Ozempic patient assistance program
- Zepbound patient assistance program
- Wegovy patient assistance program
- Drug interaction checker tool
- Patient assistance program finder
Get Formulary and Coverage Updates
Subscribe to receive alerts on formulary changes, new drug approvals, and insurance coverage updates.